Compile Data Set for Download or QSAR
Report error Found 231 Enz. Inhib. hit(s) with all data for entry = 6704
TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 148993BDBM148993(US8962648, 73 | US8962648, 72)
Affinity DataIC50: 0.380nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149054BDBM149054(US8962648, 319)
Affinity DataIC50: 0.430nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149042BDBM149042(US8962648, 276)
Affinity DataIC50: 0.5nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149041BDBM149041(US8962648, 275)
Affinity DataIC50: 0.540nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149027BDBM149027(US8962648, 235)
Affinity DataIC50: 0.570nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 148993BDBM148993(US8962648, 73 | US8962648, 72)
Affinity DataIC50: 0.630nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149118BDBM149118(US8962648, 1160)
Affinity DataIC50: 0.640nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149043BDBM149043(US8962648, 277)
Affinity DataIC50: 0.670nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149016BDBM149016(US8962648, 195)
Affinity DataIC50: 0.730nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149039BDBM149039(US8962648, 273)
Affinity DataIC50: 0.740nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149192BDBM149192(US8962648, 1309)
Affinity DataIC50: 0.740nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149034BDBM149034(US8962648, 266)
Affinity DataIC50: 0.780nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 148997BDBM148997(US8962648, 84)
Affinity DataIC50: 0.780nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149026BDBM149026(US8962648, 233)
Affinity DataIC50: 0.810nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149062BDBM149062(US8962648, 336)
Affinity DataIC50: 0.820nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149038BDBM149038(US8962648, 272)
Affinity DataIC50: 0.880nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149097BDBM149097(US8962648, 1120)
Affinity DataIC50: 0.880nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149010BDBM149010(US8962648, 187)
Affinity DataIC50: 0.900nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149074BDBM149074(US8962648, 359)
Affinity DataIC50: 0.920nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149044BDBM149044(US8962648, 278)
Affinity DataIC50: 0.970nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149169BDBM149169(US8962648, 1271)
Affinity DataIC50: 1nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149087BDBM149087(US8962648, 1082)
Affinity DataIC50: 1.10nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149007BDBM149007(US8962648, 176 | US8962648, 175)
Affinity DataIC50: 1.10nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149007BDBM149007(US8962648, 176 | US8962648, 175)
Affinity DataIC50: 1.20nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149067BDBM149067(US8962648, 345)
Affinity DataIC50: 1.20nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149112BDBM149112(US8962648, 1148)
Affinity DataIC50: 1.30nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149081BDBM149081(US8962648, 1052)
Affinity DataIC50: 1.30nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149131BDBM149131(US8962648, 1187)
Affinity DataIC50: 1.30nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149094BDBM149094(US8962648, 1111)
Affinity DataIC50: 1.30nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149104BDBM149104(US8962648, 1131)
Affinity DataIC50: 1.30nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149121BDBM149121(US8962648, 1163)
Affinity DataIC50: 1.30nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149091BDBM149091(US8962648, 1095)
Affinity DataIC50: 1.30nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149102BDBM149102(US8962648, 1127)
Affinity DataIC50: 1.40nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149159BDBM149159(US8962648, 1252)
Affinity DataIC50: 1.40nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149127BDBM149127(US8962648, 1174)
Affinity DataIC50: 1.5nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149012BDBM149012(US8962648, 192 | US8962648, 191)
Affinity DataIC50: 1.60nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149185BDBM149185(US8962648, 1300)
Affinity DataIC50: 1.70nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149140BDBM149140(US8962648, 1209)
Affinity DataIC50: 1.80nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 148992BDBM148992(US8962648, 65)
Affinity DataIC50: 1.80nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149070BDBM149070(US8962648, 348)
Affinity DataIC50: 1.90nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149071BDBM149071(US8962648, 349)
Affinity DataIC50: 1.90nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149065BDBM149065(US8962648, 339)
Affinity DataIC50: 1.90nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149012BDBM149012(US8962648, 192 | US8962648, 191)
Affinity DataIC50: 1.90nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149056BDBM149056(US8962648, 327)
Affinity DataIC50: 1.90nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149052BDBM149052(US8962648, 313)
Affinity DataIC50: 2nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149014BDBM149014(US8962648, 347 | US8962648, 193)
Affinity DataIC50: 2nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149119BDBM149119(US8962648, 1161)
Affinity DataIC50: 2nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149035BDBM149035(US8962648, 267)
Affinity DataIC50: 2nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149072BDBM149072(US8962648, 353)
Affinity DataIC50: 2nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 149103BDBM149103(US8962648, 1128)
Affinity DataIC50: 2.20nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2015
Entry Details
US Patent

Displayed 1 to 50 (of 231 total ) | Next | Last >>
Jump to: